Janice MacLennan, pharma strategy consultant and founder & CEO, Nmblr answers the question: will 2026 signal the end of business-as-usual in biopharma commercialisation?
Shannon Ryan, senior director of application services at Avantor, describes why traditional buffer preparation models are increasingly strained at large scale.
Mark Schofield, director, R&D, and Nick Marchand, senior manager, Cytiva, share how modern filtration innovations are driving intensified bioprocessing, boosting efficiency, and supporting sustainability across emerging modalities.
FUJIFILM Biotechnologies, has announced ShunzymeX precision purification technology, which simplifies downstream processing for complex biologics. The technology will be presented this week at the Festival of Biologics conference in San Diego.
Sartorius is addressing the increasing demand for faster and more efficient cell line development (CLD) by launching a new genetically engineered CHO host cell line that is designed to improve productivity and efficiency.
In this article CurTec, explores how a prepared approach to secondary bulk packaging supports predictable performance, audit confidence and continuity across biopharma supply chains.
Dr. Nicole Hunter, head of global WMArchitect single-use solutions, outlines how biopharmaceutical manufacturers and suppliers can take steps to secure a resilient supply of single-use assemblies.
SynGenSys, a biotech company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing, has announced the launch of its Liver.SET library of liver-specific synthetic promoters.
